MedTrace Logo

A Clinical Trial Comparing Monocryl and Dermabond Closure Versus Staple Closure in Total Hip Arthroplasty

NCT02519829 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 139

Last updated 2015-08-11

No results posted yet for this study

Summary

Patients undergoing primary hip arthroplasty will be randomized to receive either monocryl closure of fascial and dermal layers with dermabond and tegaderm covering versus standard vicryl closure of fascia layer and staple closure for skin. Short term wound complications, pain and patient and surgeon-rated cosmetic scar appearance will be measured. The investigators will also measure operating room time and costs associated with dressing changes and wound-related procedures (e.g. staple removal).

Conditions

  • Unilateral Primary Osteoarthritis, Unspecified Hip

Interventions

PROCEDURE

Monocryl closure

Total Hip Arthroplasty with monocryl closure of wound

PROCEDURE

Vicryl and Staple closure

Total Hip Arthroplasty with vicryl and staple closure of wound

PROCEDURE

Tegaderm dressing

Total Hip Arthroplasty with monocryl closure of wound and tegaderm dressing

PROCEDURE

Gauze dressing

Total Hip Arthroplasty with vicryl and staple closure of wound and gauze dressing

Sponsors & Collaborators

  • London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

    lead OTHER

Principal Investigators

  • James L Howard, MD · London Health Sciences Centre

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2010-01-31
Primary Completion
2011-07-31
Completion
2013-12-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02519829 on ClinicalTrials.gov